Hydroxychloroquine May Tame Preeclampsia in Lupus Patients Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a Swedish cohort ...

Descartes-08 for patients with Systemic Lupus Erythematosus Sponsor Name: Cartesian Therapeutics Purpose of Study: This study is being conducted to evaluate the safety, tolerability, and ability to ...

Key highlights included phase 3 trial results for obinutuzumab and dapirolizumab in lupus nephritis and systemic lupus erythematosus, as well as new lupus nephritis guidelines emphasizing triple ...

References 1. FDA approves Benlysta (belimumab) autoinjector for children with systemic lupus erythematosus. News release. GSK. May 20, 2024.

About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).

ANSWER: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease, while cutaneous lupus are a group of diseases where lupus is localized to the skin. Systemic lupus often includes ...

ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter at the American Academy of Dermatology ...